Source: Annual Congress 2009 - Animal models of airways inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Fujiwara, M. Naito, T. Takagi, A. Ebihara, T. Kobayashi, H. Kobayashi, C. D‘Alessandro-Gabazza, E. Gabazza, Y. Takei, O. Taguchi (Tsu-city, Japan). Effect of a thrombin inhibitor on murine bronchial asthma. Eur Respir J 2009; 34: Suppl. 53, 2106

Member's Comments

No comment yet.

Related content which might interest you: Effect of thrombin inhalation in a murine model of bronchial asthma Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011 Effect of neutrophil elastase inhibitor on airway inflammation and airway hyperresponsiveness in a murine model of asthma Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 Effect of a pan-JAK inhibitor pyridone 6 on airway responses in murine asthma model Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010 Role of thrombin-activatable fibrinolysis inhibitor in bronchial asthma Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 Role of thrombin and thrombin receptor in the activation of human bronchial epithelial cells during airway inflammation Source: Eur Respir J 2007; 30: Suppl. 51, 523s Year: 2007 Effect of H+K+ATPase inhibitors on airway cough hypersensitivity induced by allergic inflammation in guinea pigs Source: Eur Respir J 2003; 22: Suppl. 45, 106s Year: 2003 Effects of a selective phosphodiesterase IV and V inhibitor in a murine model of chronic asthma Source: Eur Respir J 2004; 24: Suppl. 48, 128s Year: 2004 Effect of a neutrophil elastase inhibitor on airway goblet cell secretion in sensitized guinea pigs Source: Eur Respir J 2001; 18: Suppl. 33, 247s Year: 2001 Protective effect of thrombomodulin in a murine model of allergen-induced asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 The PAR2-activating peptide SLIGRL inhibits airway hyper-responsiveness and eosinophilia in an acute murine model of allergic asthma Source: Annual Congress 2004 - Animal models of asthma and chronic bronchitis and their relevance in pulmonary pharmacology Year: 2004 Activated protein C inhibits bronchial inflammation and hyperresponsiveness in a mouse model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 618s Year: 2002 Influence of acid sphingomyelinase deficiency in a murine model of allergen-induced asthma Source: Annual Congress 2011 - Animal models of airway inflammation Year: 2011 Effect of anti-IL17 and/or Rho-kinase inhibitor treatments on vascular remodelling in an asthma model in mice Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets Year: 2019 Role of of symbicort in treatment of bronchial asthma Source: Annual Congress 2010 - Treatment options for asthma Year: 2010 Influence of endogenous corticosteroids on bronchial protective properties of β2-agonist in patients with bronchial asthma with cold bronchial hyperresponsiveness Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010 Role of mouse mast cell protease 4 in a murine model of allergic asthma Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma Year: 2007 Effect of verapamil on bronchial goblet cells of asthma Source: Annual Congress 2010 - Models of airways disease Year: 2010 Effect of oral procaterol on allergic inflammation examined by a murine asthmatic model Source: Eur Respir J 2003; 22: Suppl. 45, 286s Year: 2003 Assessment of in vivo 5-lipoxygenase (5-LO) activity in nonatopic and atopic subjects with or without asthma: effects of treatment with the 5-LO inhibitor zileuton Source: Eur Respir J 2003; 22: Suppl. 45, 101s Year: 2003 Effect of 1,25(OH)2D3 on the airway inflammation in asthmatic rat model Source: Eur Respir J 2005; 26: Suppl. 49, 580s Year: 2005